Yu DH, Hung MC: Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene. 2000, 19: 6115-6121. 10.1038/sj.onc.1203972.
Article
CAS
PubMed
Google Scholar
Kraus M, Popescu N, Amsbaugh S, King C: Overexpression of the EGF receptor-related proto-oncogene erbB-2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J. 1987, 6: 605-610.
CAS
PubMed
PubMed Central
Google Scholar
Bates NP, Hurst HC: Transcriptional regulation of type I receptor tyrosine kinases in the mammary gland. J Mammary Gland Biol Neoplasia. 1997, 2: 153-163. 10.1023/A:1026303814855.
Article
CAS
PubMed
Google Scholar
Scott GK, Chang CH, Erny KM, Xu F, Fredericks WJ, Rauscher FJ, Thor AD, Benz CC: Ets regulation of the erbB2 promoter. Oncogene. 2000, 19: 6490-6502. 10.1038/sj.onc.1204041.
Article
CAS
PubMed
Google Scholar
Ishii S, Imamoto F, Yamanishi Y, Toyoshima K, Yamamoto T: Characterisation of the promoter region of the human c-erbB-2 protooncogene. Proc Natl Acad Sci USA. 1987, 84: 4374-4378.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tal M, King C, Kraus M, Ullrich A, Schlessinger J, Givol D: Human her2 (neu) promoter: evidence for multiple mechanisms for transcriptional initiation. Mol Cell Biol. 1987, 7: 2597-2601.
Article
CAS
PubMed
PubMed Central
Google Scholar
Scott G, Daniel J, Xiong X, Maki R, Kabat D, Benz C: Binding of an ETS-related Protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cells. J Biol Chem. 1994, 269: 19848-19858.
CAS
PubMed
Google Scholar
Bates NP, Hurst HC: An intron 1 enhancer element mediates oestrogen-induced suppression of ERBB2 expression. Oncogene. 1997, 15: 473-481. 10.1038/sj.onc.1201368.
Article
CAS
PubMed
Google Scholar
Nezu M, Sasaki H, Kuwahara Y, Ochiya T, Yamada Y, Sakamoto H, Tashiro H, Yamazaki M, Ikeuchi T, Saito Y, Terada M: Identification of a novel promoter and exons of the c-ERBB-2 gene. Biochem Biophys Res Commun. 1999, 258: 499-505. 10.1006/bbrc.1999.0634.
Article
CAS
PubMed
Google Scholar
Hollywood DP, Hurst HC: A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumour lines. EMBO J. 1993, 12: 2369-2375.
CAS
PubMed
PubMed Central
Google Scholar
Bosher JM, Williams T, Hurst HC: The developmentally regulated transcription factor AP-2 is involved in c-erbB-2 overexpression in human mammary carcinoma. Proc Natl Acad Sci USA. 1995, 92: 744-747.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bosher JM, Totty NF, Hsuan JJ, Williams T, Hurst HC: A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene. 1996, 13: 1701-1707.
CAS
PubMed
Google Scholar
Turner BC, Zhang J, Gumbs AA, Maher MG, Kaplan L, Carter D, Glazer PM, Hurst HC, Haffty BC, Williams T: Expression of AP-2 transcription factors in human breast cancer correlates with the regulation of multiple growth factor signalling pathways. Cancer Res. 1998, 58: 5466-5472.
CAS
PubMed
Google Scholar
Xing XM, Wang SC, Xia WY, Zou YY, Shao RP, Kwong KY, Yu ZM, Zhang S, Miller S, Huang L, Hung MC: The Ets protein PEA3 suppresses HER-2/neu overexpression and inhibits tumorigenesis. Nat Med. 2000, 6: 189-195. 10.1038/72294.
Article
CAS
PubMed
Google Scholar
Benz CC, O'Hagan RC, Richter B, Scott GK, Chang CH, Xiong XH, Chew K, Ljung BM, Edgerton S, Thor A, Hassell JA: Her2/neu and the ets transcription activator PEA3 are co-ordinately up-regulated in human breast-cancer. Oncogene. 1997, 15: 1513-1525. 10.1038/sj.onc.1201331.
Article
CAS
PubMed
Google Scholar
Hollywood DP, Hurst HC: Targeting gene transcription: a new strategy to downregulate c-erbB-2 expression in mammary carcinoma. Br J Cancer. 1995, 71: 753-757.
Article
CAS
PubMed
PubMed Central
Google Scholar
Chiang SY, Burli RW, Benz CC, Gawron L, Scott GK, Dervan PB, Beerman TA: Targeting the Ets binding site of the HER2/neu promoter with pyrrole-imidazole polyamides. J Biol Chem. 2000, 275: 24246-24254. 10.1074/jbc.M000820200.
Article
CAS
PubMed
Google Scholar
Okada T, Amanuma H, Okada Y, Obata M, Hayashi Y, Yamaguchi K, Yamashita J: Inhibition of gene-expression from the human c-erbB gene promoter by a retroviral vector expressing antigene RNA. Biochem Biophys Res Commun. 1997, 240: 203-207. 10.1006/bbrc.1997.7563.
Article
CAS
PubMed
Google Scholar
Beerli RR, Segal DJ, Dreier B, Barbas CF: Toward controlling gene-expression at will: specific regulation of the erbb-2/her-2 promoter by using polydactyl zinc-finger proteins constructed from modular building-blocks. Proc Natl Acad Sci USA. 1998, 95: 14628-14633. 10.1073/pnas.95.25.14628.
Article
CAS
PubMed
PubMed Central
Google Scholar
Harris J, Gutierrez AA, Hurst HC, Sikora K, Lemoine NR: Gene therapy for cancer using tumour-specific prodrug activation. Gene Ther. 1994, 1: 170-175.
CAS
PubMed
Google Scholar
Pandha HS, Martin LA, Rigg A, Hurst HC, Stamp GWH, Sikora K, Lemoine NR: Genetic prodrug activation therapy for breast cancer: a phase I clinical trial of ERBB2-directed suicide gene expression. J Clin Oncol. 1999, 17: 2180-2189.
CAS
PubMed
Google Scholar
Vassaux G, Hurst HC, Lemoine NR: Insulation of a conditionally expressed transgene in an adenoviral vector. Gene Ther. 1999, 6: 1192-1197. 10.1038/sj.gt.3300910.
Article
CAS
PubMed
Google Scholar
Ring CJA, Blouin P, Martin LA, Hurst HC, Lemoine NR: Use of transcriptional regulatory elements of the MUC1 and ERBB2 genes to drive tumour-selective expression of a prodrug-activiating enzyme. Gene Ther. 1997, 4: 1045-1052. 10.1038/sj.gt.3300510.
Article
CAS
PubMed
Google Scholar
Stackhouse MA, Buchsbaum DJ, Kancharla SR, Grizzle WE, Grimes C, Laffoon K, Pederson LC, Curiel DT: Specific membrane receptor gene expression targeted with radiolabeled peptide employing the erbB-2 and DF3 promoter elements in adenoviral vectors. Cancer Gene Ther. 1999, 6: 209-219. 10.1038/sj.cgt.7700049.
Article
CAS
PubMed
Google Scholar
Balda MS, Matter K: The tight junction protein ZO-1 and an interacting transcription factor regulate ErbB-2 expression. EMBO J. 2000, 19: 2024-2033. 10.1093/emboj/19.9.2024.
Article
CAS
PubMed
PubMed Central
Google Scholar